ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

Characterization of Biosimilar Monoclonal Antibodies and Their Reference Products Approved in Japan to Reveal the Quality Characteristics in Post-approval Phase.

Hiroko Shibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.